LISTEN LIVE!
Oct 12 (Reuters) – Bristol Myers Squibb said on Monday its experimental drug met the main goal of a late-stage trial in patients with idiopathic pulmonary fibrosis, a serious lung-scarring disease.
(Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Sahal Muhammed)
Brought to you by www.srnnews.com
Follow Us
Recent Posts
Related Posts:
ROCHESTER, N.Y. – Cloudy and quiet weather to start the new week on this Columbus Day/Indigenous Peoples’ Day. Heavier clouds...
ROCHESTER, N.Y. — A man is charged with assault after Rochester Police say he stabbed another man at the corner of Kenwood and...
ROCHESTER, N.Y. — Monday marks both Columbus Day and Indigenous Peoples Day. Columbus Day became a federal holiday in 1934. In...